1,3-Dihydroimidazo[4,5-b]pyridin-2-one - CAS 16328-62-4

Catalog:	BB011984
Product Name:	1,3-Dihydroimidazo[4,5-b]pyridin-2-one
CAS:	16328-62-4
Synonyms:	1,3-dihydroimidazo[4,5-b]pyridin-2-one; 1,3-dihydroimidazo[4,5-b]pyridin-2-one

Technical Data

Safety and Hazards

Patents

Literatures

Computed Properties

IUPAC Name:	1,3-dihydroimidazo[4,5-b]pyridin-2-one
Description:	1,3-Dihydroimidazo[4,5-b]pyridin-2-one (CAS# 16328-62-4) is a useful research chemical.
Molecular Weight:	135.12
Molecular Formula:	C6H5N3O
Canonical SMILES:	C1=CC2=C(NC(=O)N2)N=C1
InChI:	InChI=1S/C6H5N3O/c10-6-8-4-2-1-3-7-5(4)9-6/h1-3H,(H2,7,8,9,10)
InChI Key:	PGDIPOWQYRAOSK-UHFFFAOYSA-N
Boiling Point:	146.7 °C at 760 mmHg
Density:	1.346 g/cm³
Appearance:	Solid
MDL:	MFCD00464845
LogP:	0.25120

Publication Number	Title	Priority Date
WO-2021055591-A1	Substituted benzimidazole carboxamides and their use in the treatment of medical disorders	20190917
FR-3099931-A1	Branched and functionalized alkanes and their preparation process	20190816
WO-2020240586-A1	Novel compounds for inhibition of janus kinase 1	20190528
JP-2020123477-A	Light emitting device, display device and lighting device	20190130
US-2020140411-A1	2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors	20181102

PMID	Publication Date	Title	Journal
27117263	20160601	Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors	Bioorganic & medicinal chemistry
19473026	20090709	Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring	Journal of medicinal chemistry

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Imidazopyridines

[478040-70-9]
Ethyl 3-bromo-6-iodoimidazo[1,2-a]pyridine-2-carboxylate
[2702837-08-7]
Ethyl 3-bromo-8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
[1628264-05-0]
6-Bromo-2-ethyl-N-methylimidazo[1,2-a]pyridin-3-amine
[5028-32-0]
1-Methyl-1H-imidazo[4,5-c]pyridine
[1421312-22-2]
Ethyl 8-bromo-6-fluoroimidazo[1,2-a]pyridine-2-carboxylate
[1229620-12-5]
N-(3-Bromoimidazo[1,2-a]pyridin-8-yl)acetamide

GHS Hazard Statement:	H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Signal Word:	Warning

Complexity:	159
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	135.043261791
Formal Charge:	0
Heavy Atom Count:	10
Hydrogen Bond Acceptor Count:	2
Hydrogen Bond Donor Count:	2
Isotope Atom Count:	0
Monoisotopic Mass:	135.043261791
Rotatable Bond Count:	0
Topological Polar Surface Area:	54 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	-0.2